ARGX:NASDAQ
argenx SE - ADR
US$ ९१२.८७
arrow_downward
-०.६९%(-६.३४) 1D
US$ ९३०.६८
arrow_upward
+१.९५% (+१७.८१)todayPre-market
Closed: अक्टोबर ५, १६:००:०२ GMT-४ · USD
search
All symbols
| Symbol | Price | Change | % Change |
|---|
insights_autoGenerating top insights for ARGX...
Open
US$ ९२०.८२
High
US$ ९२३.३१
Low
US$ ९०३.५०
Mkt. cap
५६.९५ अरब
Avg. vol.
२.५८ लाख
Volume
२२०.००
P/E ratio
३४.६८
52-wk high
US$ १,०७२.७५
52-wk low
US$ ६६१.८५
EPS
US$ २६.३२
Beta
०.४५
Shares outstanding
६.२६ करोड
No. of employees
२ हजार
Open
US$ ९२०.८२
High
US$ ९२३.३१
Low
US$ ९०३.५०
Mkt. cap
५६.९५ अरब
Avg. vol.
२.५८ लाख
Volume
२२०.००
P/E ratio
३४.६८
52-wk high
US$ १,०७२.७५
52-wk low
US$ ६६१.८५
EPS
US$ २६.३२
Beta
०.४५
Shares outstanding
६.२६ करोड
No. of employees
२ हजार
News stories
From web sources and news partners
AD HOC NEWS
·
१३ घण्टा पहिले
Argenx stock gets fresh VYVGART data before Q3 results
Zacks
·
१८ घण्टा पहिले
BMY or ARGX: Which Is the Better Value Stock Right Now?
Yahoo Finance UK
·
१९ घण्टा पहिले
BMY or ARGX: Which Is the Better Value Stock Right Now?
AD HOC NEWS
·
१ दिन पहिले
argenx presents Vyvgart data: Goldman lifts argenx stock target to EUR 982.00
Profile
Argenx SE is a Belgian-Dutch pharmaceutical company specializing in immunology. Argenx specializes in the development of antibody therapies for the treatment of autoimmune diseases and cancer. Its work primarily focuses on the development of orphan drugs. Wikipedia
About argenx SE - ADR